ZNF418 and gastric cancer: Only a few studies documented that ZNF418 negatively regulated transcription and the MAPK signaling pathway (Li et al., 2008) and that lower expression of ZNF418 was associated with poorer prognosis in gastric cancer (Hui et al., 2018).